WallStreetZenWallStreetZen

NASDAQ: MXCT
Maxcyte Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Maxcyte earnings were -$44.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MXCT earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$12.4M, up 20.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MXCT reported annual earnings of -$41.1M, with 8.3% growth. The next MXCT earnings date is Nov 5, 2025.

MXCT earnings history

Current Revenue
$35.8M
Current Earnings
-$44.8M
Current Profit Margin
-125.2%

MXCT Return on Equity

Current Company
-22.1%
Current Industry
15.2%
Current Market
30.7%
MXCT's Return on Equity (-22.1%)... subscribe to Premium to read more.
High Return on Equity Performance

MXCT undefined

Current Company
-19.1%
Current Industry
8.9%
MXCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MXCT announces earnings.

MXCT undefined

Current Company
-21.5%
Current Industry
10.6%
MXCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MXCT vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MXCT-$39.83M-$44.77MN/A-$0.43
RCEL-$49.49M-$57.05MN/A-$2.19
LNSR-$51.96M-$56.59MN/A-$4.86
SGHT-$43.14M-$49.40MN/A-$0.99
CVRX-$46.15M-$52.25MN/A-$2.07
View Top Medical Device Stocks

MXCT earnings dates

Next earnings date
Nov 5, 2025

Maxcyte Earnings Reports & History FAQ

What were Maxcyte's earnings last quarter?

On MXCT's earnings call on Invalid Date, Maxcyte (NASDAQ: MXCT) reported Q2 2025 earnings per share (EPS) of -$0.12, up 33.33% year over year. Total MXCT earnings for the quarter were -$12.36 million. In the same quarter last year, Maxcyte's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Maxcyte stock.

When does Maxcyte report earnings?

The next MXCT earnings date is Invalid Date. Add MXCT to your watchlist to be reminded of Maxcyte's next earnings date.

Is Maxcyte profitable or losing money?

As of the last Maxcyte earnings report, Maxcyte is currently losing money. Maxcyte's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$44.77 million, a 26.37% increase year over year.

What was MXCT's earnings growth in the past year?

As of Maxcyte's earnings date in Invalid Date, Maxcyte's earnings has grown year over year. MXCT earnings in the past year totalled -$44.77 million.

What are Maxcyte's earnings expectations?

The current EPS estimate for Maxcyte's earnings report in Invalid Date is -$0.10.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.